Acenocoumarol

Acenocoumarol is an oral anticoagulant medication used for the prevention and treatment of abnormal blood clotting. It works by inhibiting the activity of Vitamin K-dependent clotting factors, thereby reducing the risk of blood clot formation.
Acenocoumarol is primarily prescribed for patients with conditions such as deep vein thrombosis, pulmonary embolism, and atrial fibrillation, where the risk of clot formation is elevated. It is also used in patients with mechanical heart valves to prevent clotting on the valve surfaces.
The drug is typically initiated under close medical supervision, as it requires regular monitoring of the patient’s blood clotting time (International Normalized Ratio or INR) to ensure the medication is working effectively and to minimize the risk of excessive bleeding.
Patients should be aware that acenocoumarol has a narrow therapeutic range, which means that the difference between an effective dose and a toxic dose is small. Therefore, regular monitoring and dose adjustments are crucial to maintain optimal blood clotting levels and to minimize the risk of adverse effects.